Brought to you by 
DJ Pharma gets Cedax antibiotic from Schering-Plough
30 Aug 2004
Executive Summary
In-licenser DJ Pharma has signed for the US marketing rights to Schering-Plough's Cedax (ceftibuten), a broad-spectrum oral cephalosporin antibiotic.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
DJ Pharma gets Cedax antibiotic from Schering-Plough
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice